Shaul Ozeri
NovaPulse
Former names:
Treatment for Peripheral Artery Disease
NovaPulse
About
NovaPulse is a bioconvergence company specializing in the multibillion-dollar peripheral artery disease market. The company is focused on helping the millions of claudication patients who suffer from pain and have trouble walking because of insufficient blood supply to their legs.
NovaPulse is the brainchild of the MEDX Xelerator incubator.
NovaPulse is the brainchild of the MEDX Xelerator incubator.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
2
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,